News

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
FDA Commissioner Dr Marty Makary said the early launch of the large language model (LLM) AI, called Elsa, also came in under budget, "thanks to the collaboration of our in-house experts" across ...